IDEXX Laboratories Q2 2025 Earnings Preview: EPS and Revenue Estimates

IDEXX Laboratories is set to announce Q2 2025 earnings on August 4th. The consensus EPS estimate is $3.30 (+9.3% Y/Y) and the consensus revenue estimate is $1.07B (+6.6% Y/Y). Over the last 2 years, IDXX has consistently beaten EPS estimates by an average of 6.4%.

IDEXX Laboratories (NASDAQ: IDXX) is scheduled to release its second-quarter 2025 earnings results on Monday, August 4th, before the market opens. The consensus estimate for earnings per share (EPS) is $3.30, representing a 9.3% year-over-year (Y/Y) increase, while the consensus revenue estimate stands at $1.07 billion, indicating a 6.6% Y/Y growth. Over the last two years, IDEXX has consistently outperformed EPS estimates by an average of 6.4% [1].

The company's strong performance is driven by several factors. The Companion Animal Group (CAG) is expected to have benefited from global net price improvement and higher volumes, with IDEXX VetLab consumables revenue growth likely driven by higher price realization and volume increases. International CAG Diagnostic recurring revenues are also anticipated to have benefited from new business gains, contributing to the robust expansion of IDEXX's premium instrument installed base. The Water and Livestock, Poultry, and Dairy (LPD) segments are also expected to have delivered solid revenues, with the Water segment benefiting from realized price increases and higher volumes, and the LPD division maintaining U.S. momentum [2].

IDEXX Laboratories' innovations, such as the IDEXX Cancer Dx diagnostic panel for canine lymphoma and the CatalystSmartQC Control, have gained commercial traction and are expected to have positively impacted the company's second-quarter revenues. The company's Zacks Rank of #3 and Earnings ESP of +0.34% suggest a higher likelihood of beating estimates [2].

Investors and financial professionals should closely monitor IDEXX Laboratories' earnings announcement for further insights into the company's performance and future prospects.

References:
[1] https://seekingalpha.com/news/4476706-idexx-laboratories-q2-2025-earnings-preview
[2] https://finance.yahoo.com/news/idexx-release-q2-earnings-whats-115600147.html